News
While CIML natural killer immunotherapy can result in infection-like reactions, required prior chemo may cause infections, ...
Panelists discuss updated MonumenTAL-1 trial data demonstrating high response rates and prolonged survival with ...
Panelists discuss updated safety findings from GPRC5D-targeted bispecific therapy in relapsed/refractory multiple myeloma, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback